On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
Save 20% on Press Releases and More with NNW Prime! Click to View Details
FridaySep 17, 2021 9:15 am

FuelPositive Corp. (TSX.V: NHHH) (OTCQB: NHHHF) Phase Two Growth Plans, CEO Interview on Gamechangers LIVE

FuelPositive announced four new appointments – Nelson Leite and Olushola Ashiru have joined the Board, while Francois Desloges and Jennifer Spencer have been appointed to the Executive Leadership Team The appointments are in a move to actualize Phase Two of the company’s Hydrogen-Ammonia Synthesizer commercial prototype system, critical to its future growth FuelPositive’s CEO expressed enthusiasm with the new appointments, citing that they will be integral to the company’s plans for creating and developing technologies and solutions to fight climate change The company’s CEO also appeared on the Gamechangers LIVE podcast, where he shared his personal story, background, mindset, struggles…

Continue Reading

FridaySep 17, 2021 9:15 am

Nemaura Medical Inc. (NASDAQ: NMRD) Is ‘One to Watch’

Nemaura’s flagship product, sugarBEAT(R), is a wearable, non-invasive and flexible Continuous Glucose Monitor (“CGM”) designed for people with diabetes and prediabetes sugarBEAT received CE mark clearance in May 2019, allowing it to be marketed and sold within the European Union, and Nemaura has submitted a premarket approval application to the U.S. FDA Nemaura continues to build a world-class management team Nemaura plans to launch a direct to consumer metabolic health program in 2021, using its glucose monitoring platform at the core of the program Nemaura has several patents (both filed and pending) and substantial trade secrets covering its technology platform…

Continue Reading

FridaySep 17, 2021 9:00 am

InMed Pharmaceuticals Inc. (NASDAQ: INM) Signs Definitive Agreement to Acquire 100% of BayMedica Inc., Positioning it to Stand Distinct in Rare Cannabinoids Manufacturing, Become a Revenue-Generating Company, Expand Drug Development Capabilities

InMed Pharmaceuticals recently announced it has entered a definitive agreement to acquire 100% of BayMedica Inc. BayMedica is a private company that specializes in the manufacture and commercialization of rare cannabinoids Upon closing, the transaction will make InMed a global leader in the manufacturing of rare cannabinoids in addition to transforming it into a revenue-generating company Acquisition provides InMed with the complete flexibility across multiple manufacturing approaches On September 13, InMed Pharmaceuticals (NASDAQ: INM), a company developing cannabinoid-based pharmaceutical drug candidates and manufacturing technologies for pharmaceutical-grade rare cannabinoids, announced it has signed a definitive agreement to acquire 100% of BayMedica…

Continue Reading

FridaySep 17, 2021 9:00 am

Differentiated Approach in Psychedelics Boosts Confidence in Upcoming Clinical Trials for Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF)

Pharmaceutical company Tryp Therapeutics is pursuing novel solutions to medical conditions with unmet needs, working to establish the efficacy and safety of the company’s trademarked synthetic psychedelic drug candidate The company’s products — TRP-8802 and TRP-8803 — aim to provide new therapies for select eating disorders with specific neurological causes, as well as pain and addition concerns Tryp is preparing Phase 2a and Phase 2b clinical trials and expects to advance its Psilocybin-for-Neuropsychiatric Disorders (“PFN”) platform in conjunction with research teams at the University of Florida and the University of Michigan The DEA recently recommended a significant increase in cannabis…

Continue Reading

FridaySep 17, 2021 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Draws Closer to NDA Filing for DehydraTECH CBD

Lexaria just released the most important results yet from its ongoing HYPER-H21-2 human clinical trials on the effects of the company’s patented DehydraTECH(TM)-processed CBD on blood pressure Chris Bunka, Lexaria’s CEO, termed the results as “statistically significant” Participants in the study reported up to an average 23% decrease in blood pressure and a 7% drop in systolic pressure These results bring Lexaria closer to NDA filing with the FDA, making it a pioneer in CBD hypertension treatment  Lexaria Bioscience (NASDAQ: LEXX) just released the most recent results from its ongoing HYPER-H21-2 human clinical trials on the effects of the company’s…

Continue Reading

ThursdaySep 16, 2021 1:30 pm

MoneyShow Presents The World of ETF Investing Canada Virtual Expo Featuring 35+ World-Class Industry Experts

Date: Sept. 21-22, 2021 Virtual event Free registration Investors and traders are invited to attend the ETF Investing Canada Virtual Expo organized by MoneyShow on September 21-22, 2021. MoneyShow is trusted by millions of investors and traders for its global network of investing and trading experts The company is engaged in hosting award-winning in-person conferences, virtual events, and timely content online where industry experts offer their valuable insights on the current and future investment trends. With investors and traders increasingly using ETFs in their portfolios, this investment vehicle is attracting billions of dollars from the global financial ecosystem. However, with…

Continue Reading

ThursdaySep 16, 2021 1:16 pm

Roth’s Investing in Women Cannabis Pioneers Investor Conference to Feature Female-Led Companies within the North American Cannabis Sector

Roth Capital Partners will host the “Women Cannabis Pioneers - The Brand Builders” event on September 28, 2021 The conference is set to feature approximately 25 privately held and female-led companies operating within the North American cannabis market Institutional investors will have an opportunity to discover new investment opportunities through their interaction with a host of emerging and lesser-known privately held companies  Hosted by Roth Capital Partners (“Roth”), a widely respected independent securities research and trading firm specializing in emerging growth companies, the Investing in Women Cannabis Pioneers – The Brand Builders event has been uniquely designed to highlight the…

Continue Reading

ThursdaySep 16, 2021 12:14 pm

Ideanomics Inc. (NASDAQ: IDEX) Growing its Strategic Advantage as a Global Provider of EV Mobility Solutions with the Appointment of New President of its Mobility Division

Robin Mackie new President of Ideanomics Mobility, as of September 8, 2021 Mackie will help the company to make the most out of its acquisitions, driving growth on its path to a zero-emission future He will also help Ideanomics expand its global talent pool to further develop its key advantage as a global provider of EV mobility solutions Mackie brings a wealth of knowledge and decades of experience in the EV sector On September 8, 2021, Ideanomics (NASDAQ: IDEX) announced the appointment of Robin Mackie as the new President of Ideanomics Mobility.  Before he was appointed President, Mr. Mackie served…

Continue Reading

ThursdaySep 16, 2021 11:53 am

PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) to Launch as Seller on Amazon Marketplace; Commence NCIB of 5% Available Common Shares for Cancelation

The company will be utilizing Amazon’s fulfillment services, customer service, and network of affiliates in the U.S. and Canada The Amazon platform will also feature PlantX-label plant-based brands and products for sale The overall PlantX platform features a one-stop shop for all things plant-based, including grocery, meal delivery, The Plant Shop, weekly recipes, and more The company is preparing to begin NCIB on or around September 15, 2021, through September 14, 2022. The shares represent approximately 5% (6,071,757) of the common shares available for purchase.  Through PI Financial Corp., the company will make the purchase of the common shares for…

Continue Reading

ThursdaySep 16, 2021 11:42 am

Growth of China’s Tech Use Boosts Prospects for Mobile Services and Big Data Provider FingerMotion Inc. (FNGR)

U.S.-based FingerMotion is a mobile phone services and emerging big data technology company focused on the enormous prospects of China’s marketplace FingerMotion’s drive to develop its new Sapientus database IP has led to a significant agreement for providing big data to global insurance juggernaut Pacific Life’s Reinsurance division Pacific Life is among a number of outsider companies looking to enter China’s marketplace, and FingerMotion’s data is expected to help the company establish risk prediction profiles for its clientele China boasts a population of about 1.4 billion people, of whom more than half have adopted mobile phone technology during the past…

Continue Reading

NetworkNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 212.418.1217